TELA 8-K 2026-09-29

TELA Bio, Inc. (TELA) 8-K dated 2026-09-29 — accession 0001104659-26-111920. This URL is the filing, not the TELA hub.

TELA Bio, Inc. (TELA) is a medical devices company listed on NASDAQ.

TELA Bio, Inc. filed a 8-K on 2026-09-29. Accession 0001104659-26-111920.

Cached items: 1.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported TELA revenue for 2025-12-31 was $80.3M. Net income was -$38.8M. Revenue was up 15.8% from 2024-12-31 to 2025-12-31. TELA currently screens at market cap $38.5M.

Not investment advice. The TELA SEC hub lists recent forms. The stock page is the research view.